Trial intelligence / Profile preview

Effectiveness of Cyclogest versus Duphaston for Luteal Phase Support in Infertility

IRCT20200825048515N32Phase 2Completed

Sponsor
Isfahan University of Medical Sciences
Start
Jun 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 2 trial of progesterone and dydrogesterone in female infertility (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoint: Primary effectiveness of luteal phase support. Started Jun 2021; status: completed.

02

Drugs

progesteronedydrogesterone
03

Conditions

female infertility

Beyond the preview

Go deeper on IRCT20200825048515N32.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20200825048515N32.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call